Specifically, 94.8% and 86.3% of the variants in the ND1 gene, and 72.7% and 77.7% of the variants in the COIII gene led to an amino acid change in COVID-19 patients and controls, respectively. This evidence concerns the gene MT-ND1 and COVID-19.